Post-earnings recap
Reported
Tue, Nov 4, 2025
EPS actual
$0.47
EPS est.
$0.00
EPS surprise
+15566.67%
1-day move
-2.74%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
The earnings report shows that Soleno Therapeutics delivered a surprising EPS performance, significantly exceeding expectations. However, the stock fell by 2.74%, likely due to the absence of revenue figures and guidance, which may have left investors uncertain about future growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.47 | N/A | +15566.67% |
| Revenue | N/A | N/A | N/A |
Management expressed cautious optimism about the future, focusing on the significant EPS surprise. However, they did not provide any revenue guidance.
Management highlighted the strong performance in EPS despite the lack of revenue guidance.
They emphasized ongoing efforts to enhance operational efficiency.